Clinical Trial Update: Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating two chimpanzee adenoviral vector vaccines in adults with chronic hepatitis B on nucleoside therapy; trial status is ACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Chimpanzee adenoviral vector (Vector A)
• Chimpanzee adenoviral vector (Vector B)

Snippet

Sponsor: Virion Therapeutics | Conditions: Chronic Hepatitis B | Phase 1 | Status: ACTIVE_NOT_RECRUITING